Gino Villetti

2.8k total citations
111 papers, 1.8k citations indexed

About

Gino Villetti is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Gino Villetti has authored 111 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pulmonary and Respiratory Medicine, 41 papers in Physiology and 27 papers in Molecular Biology. Recurrent topics in Gino Villetti's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (28 papers), Asthma and respiratory diseases (22 papers) and Neonatal Respiratory Health Research (20 papers). Gino Villetti is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (28 papers), Asthma and respiratory diseases (22 papers) and Neonatal Respiratory Health Research (20 papers). Gino Villetti collaborates with scholars based in Italy, France and United States. Gino Villetti's co-authors include Maurizio Civelli, Fabrizio Facchinetti, Bruno P. Imbimbo, Francesca Ruscitti, Fabio Stellari, Claudio Pietra, Francesca Ravanetti, Chiara Carnini, M. A. C. M. Bergamaschi and Vladimiro Pietrini and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Gino Villetti

110 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gino Villetti Italy	24	681	665	483	296	197	111	1.8k
Valérie Capra Italy	29	805 1.2×	242 0.4×	1.0k 2.2×	370 1.3×	468 2.4×	59	2.5k
Heledd Jarosz-Griffiths United Kingdom	17	503 0.7×	212 0.3×	674 1.4×	92 0.3×	110 0.6×	23	1.3k
Hua Zhou China	24	602 0.9×	126 0.2×	1.0k 2.1×	233 0.8×	199 1.0×	79	2.4k
Sébastien Fuchs United States	31	236 0.3×	161 0.2×	1.2k 2.5×	226 0.8×	162 0.8×	71	2.9k
Sandra J. Olson United States	33	563 0.8×	543 0.8×	1.2k 2.6×	254 0.9×	222 1.1×	49	3.1k
Rod Flower United Kingdom	19	208 0.3×	180 0.3×	723 1.5×	328 1.1×	113 0.6×	35	1.7k
Nobuo Ida Japan	23	1.5k 2.2×	124 0.2×	1.2k 2.6×	349 1.2×	233 1.2×	32	2.9k
Céline Morissette Canada	14	489 0.7×	69 0.1×	434 0.9×	216 0.7×	128 0.6×	21	1.2k
Giancarlo Folco Italy	34	1.2k 1.8×	394 0.6×	729 1.5×	627 2.1×	304 1.5×	107	2.9k
Takuya Kobayashi Japan	16	489 0.7×	211 0.3×	385 0.8×	320 1.1×	124 0.6×	61	1.5k

Countries citing papers authored by Gino Villetti

Since Specialization

Citations

This map shows the geographic impact of Gino Villetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gino Villetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gino Villetti more than expected).

Fields of papers citing papers by Gino Villetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gino Villetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gino Villetti. The network helps show where Gino Villetti may publish in the future.

Co-authorship network of co-authors of Gino Villetti

This figure shows the co-authorship network connecting the top 25 collaborators of Gino Villetti. A scholar is included among the top collaborators of Gino Villetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gino Villetti. Gino Villetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grandi, Andrea, et al.. (2024). A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(6). L736–L753. 2 indexed citations

Pennati, Francesca, Sasha Belenkov, Nicola Sverzellati, et al.. (2024). Multiphase micro-computed tomography reconstructions provide dynamic respiratory function in a mouse lung fibrosis model. iScience. 27(3). 109262–109262. 2 indexed citations

Martucci, Cataldo, Nadia Moretto, Valentina Bagnacani, et al.. (2024). CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder. Frontiers in Pharmacology. 15. 1343941–1343941. 3 indexed citations

Grandi, Andrea, Gino Villetti, Nicola Sverzellati, et al.. (2024). Quantitative micro-CT-derived biomarkers elucidate age-related lung fibrosis in elder mice. Respiratory Research. 25(1). 393–393. 2 indexed citations

Pitozzi, Vanessa, Paola Caruso, Silvia Pontis, et al.. (2023). Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes. BMJ Open Respiratory Research. 10(1). e001476–e001476. 4 indexed citations

Chinello, Clizia, Andrew Smith, Gino Villetti, et al.. (2023). Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model. International Journal of Molecular Sciences. 24(5). 4410–4410. 10 indexed citations

Cermola, Federica, Francesca Ricci, Gino Villetti, et al.. (2023). Budesonide Analogues Preserve Stem Cell Pluripotency and Delay 3D Gastruloid Development. Pharmaceutics. 15(7). 1897–1897. 2 indexed citations

Grandi, Andrea, Laura Mecozzi, M. Zoboli, et al.. (2023). Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(2). L211–L227. 12 indexed citations

Tiberio, Laura, et al.. (2023). Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases. Pharmaceutics. 15(9). 2254–2254. 4 indexed citations

10.

Schioppa, Tiziana, Valentina Salvi, Norma Maugeri, et al.. (2022). The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils. International Journal of Molecular Sciences. 23(9). 4982–4982. 4 indexed citations

11.

Stellari, Fabio, Valentina Franceschi, Francesca Macchi, et al.. (2021). Persistency of Mesenchymal Stromal/Stem Cells in Lungs. Frontiers in Cell and Developmental Biology. 9. 709225–709225. 18 indexed citations

12.

Giuliani, Alessandro, Luca Lorenzini, Vito Antonio Baldassarro, et al.. (2020). Effects of Topical Application of CHF6467, a Mutated Form of Human Nerve Growth Factor, on Skin Wound Healing in Diabetic Mice. Journal of Pharmacology and Experimental Therapeutics. 375(2). 317–331. 10 indexed citations

13.

Lea, Simon, Aleksandra Metryka, Jian Li, et al.. (2019). The modulatory effects of the PDE4 inhibitors CHF6001 and roflumilast in alveolar macrophages and lung tissue from COPD patients. Cytokine. 123. 154739–154739. 31 indexed citations

14.

Southworth, Thomas, Manminder Kaur, Fabrizio Facchinetti, et al.. (2018). Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients. Cytokine. 113. 68–73. 19 indexed citations

15.

Stellari, Fabio, Francesca Ruscitti, Francesca Ravanetti, et al.. (2017). Heterologous Matrix Metalloproteinase Gene Promoter Activity Allows In Vivo Real-time Imaging of Bleomycin-Induced Lung Fibrosis in Transiently Transgenized Mice. Frontiers in Immunology. 8. 199–199. 20 indexed citations

16.

Stellari, Fabio, Francesca Ruscitti, Francesca Ravanetti, et al.. (2016). In vivo monitoring of lung inflammation in CFTR-deficient mice. Journal of Translational Medicine. 14(1). 226–226. 17 indexed citations

17.

Lea, Simon, Aleksandra Metryka, Fabrizio Facchinetti, et al.. (2014). Anti-inflammatory effects of the novel phosphodiesterase type 4 inhibitor CHF6001 on COPD alveolar macrophages and lung tissue. European Respiratory Journal. 44(Suppl 58). 4861–4861. 1 indexed citations

18.

Facchinetti, Fabrizio, Nadia Moretto, Paola Caruso, et al.. (2014). In vitro pharmacological characterization of CHF6001, a novel selective phosphodiesterase 4 (PDE4) inhibitor with a robust anti-inflammatory profile. European Respiratory Journal. 44(Suppl 58). 4860–4860. 1 indexed citations

19.

Poli, G., Piera Anna Martino, P. Dall’Ara, et al.. (2012). Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie. Prion. 6(1). 62–72. 9 indexed citations

20.

Villetti, Gino, M. A. C. M. Bergamaschi, Pier Tonino Bolzoni, et al.. (2003). Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics. 306(2). 804–814. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact